These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 27715346)

  • 1. Suppression of RAGE and TLR9 by Ketamine Contributes to Attenuation of Lipopolysaccharide-Induced Acute Lung Injury.
    Yang C; Song Y; Wang H
    J Invest Surg; 2017 Jun; 30(3):177-186. PubMed ID: 27715346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of ketamine intervention for acute lung injury on RAGE and TLR9.
    Han WZ; Xu SW; Wang L
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4350-4354. PubMed ID: 30024622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ketamine attenuates sepsis-induced acute lung injury via regulation of HMGB1-RAGE pathways.
    Li K; Yang J; Han X
    Int Immunopharmacol; 2016 May; 34():114-128. PubMed ID: 26945830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Timosaponin B-II inhibits lipopolysaccharide-induced acute lung toxicity via TLR/NF-κB pathway.
    Zhang T; Wang J; Wang S; Ma C
    Toxicol Mech Methods; 2015; 25(9):665-71. PubMed ID: 26540118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of acteoside on lipopolysaccharide-induced inflammation in acute lung injury via regulation of NF-κB pathway in vivo and in vitro.
    Jing W; Chunhua M; Shumin W
    Toxicol Appl Pharmacol; 2015 Jun; 285(2):128-35. PubMed ID: 25902336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ulinastatin post-treatment attenuates lipopolysaccharide-induced acute lung injury in rats and human alveolar epithelial cells.
    Luo Y; Che W; Zhao M
    Int J Mol Med; 2017 Feb; 39(2):297-306. PubMed ID: 27959396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ketamine alleviates LPS induced lung injury by inhibiting HMGB1-RAGE level.
    Zhang Y; Zhang M; Wang CY; Shen A
    Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1830-1836. PubMed ID: 29630133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Daidzein attenuates lipopolysaccharide-induced acute lung injury via toll-like receptor 4/NF-kappaB pathway.
    Feng G; Sun B; Li TZ
    Int Immunopharmacol; 2015 Jun; 26(2):392-400. PubMed ID: 25887269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levobupivacaine attenuates lipopolysaccharide-induced acute lung injury.
    Guo D; Li K; Yang M; Zhang H; Miao Y
    Fundam Clin Pharmacol; 2016 Aug; 30(4):307-15. PubMed ID: 26991027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of P2X7/NF-κB pathways by Schisandrin B contributes to attenuation of lipopolysaccharide-induced inflammatory responses in acute lung injury.
    Cai Z; Liu J; Bian H; Cai J; Zhu G
    Arch Pharm Res; 2016 Apr; 39(4):499-507. PubMed ID: 26832323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
    Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
    Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cavidine Ameliorates Lipopolysaccharide-Induced Acute Lung Injury via NF-κB Signaling Pathway in vivo and in vitro.
    Niu X; Liu F; Li W; Zhi W; Zhang H; Wang X; He Z
    Inflammation; 2017 Aug; 40(4):1111-1122. PubMed ID: 28365871
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small interfering RNA targeting NF-κB attenuates lipopolysaccharide-induced acute lung injury in rats.
    Li N; Song Y; Zhao W; Han T; Lin S; Ramirez O; Liang L
    BMC Physiol; 2016 Dec; 16(1):7. PubMed ID: 28031043
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Esculin Inhibits the Inflammation of LPS-Induced Acute Lung Injury in Mice Via Regulation of TLR/NF-κB Pathways.
    Tianzhu Z; Shumin W
    Inflammation; 2015 Aug; 38(4):1529-36. PubMed ID: 25676436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Multiple components of Mahuang Shengma Decoction on prevention and treatment of acute lung injury based on RAGE/NF-κB signaling pathway].
    Ma YM; Zhao LJ; Liu MR; Liang K; Song B; Bai SX; Li ZY; Chai Z; Peng T
    Zhongguo Zhong Yao Za Zhi; 2021 Nov; 46(21):5693-5700. PubMed ID: 34951223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kegan Liyan oral liquid ameliorates lipopolysaccharide-induced acute lung injury through inhibition of TLR4-mediated NF-κB signaling pathway and MMP-9 expression.
    Zhang X; Sun CY; Zhang YB; Guo HZ; Feng XX; Peng SZ; Yuan J; Zheng RB; Chen WP; Su ZR; Huang XD
    J Ethnopharmacol; 2016 Jun; 186():91-102. PubMed ID: 27036629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production and application of HMGB1 derived recombinant RAGE-antagonist peptide for anti-inflammatory therapy in acute lung injury.
    Lee S; Piao C; Kim G; Kim JY; Choi E; Lee M
    Eur J Pharm Sci; 2018 Mar; 114():275-284. PubMed ID: 29292016
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of polydatin on lipopolysaccharide-induced acute lung injury through TLR4-MyD88-NF-κB pathway.
    Jiang Q; Yi M; Guo Q; Wang C; Wang H; Meng S; Liu C; Fu Y; Ji H; Chen T
    Int Immunopharmacol; 2015 Dec; 29(2):370-376. PubMed ID: 26507165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ulinastatin inhibits the inflammation of LPS-induced acute lung injury in mice via regulation of AMPK/NF-κB pathway.
    Li W; Qiu X; Jiang H; Zhi Y; Fu J; Liu J
    Int Immunopharmacol; 2015 Dec; 29(2):560-567. PubMed ID: 26481965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Heparin attenuates lipopolysaccharide-induced acute lung injury by inhibiting nitric oxide synthase and transforming growth factor -β/Smad signaling pathway].
    Mu E; Ding R; An X; Li X; Chen S; Ma X
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 Nov; 26(11):810-4. PubMed ID: 25399896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.